From the *Nuclear Medicine Department, Hospital General Universitario de Ciudad Real; †Medical Oncology Department, Complejo Hospitalario de Toledo; ‡Medical Oncology Department, Hospital La Mancha Centro, Alcázar de San Juan (Ciudad Real); and §Medical Oncology Department, Hospital General Universitario de Guadalajara, Spain.
Received for publication February 28, 2017; revision accepted July 13, 2017.
Compliance with Ethical Standards.
Conflicts of interest and sources of funding: none declared.
Research involving human participants and/or animals: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
No disclaimer.
All the authors have participated in the writing and revision of this article and take public responsibility for its content.
The authors and the responsible authorities where the work was carried out approved the present publication.
The authors confirm the fact that the article is not under consideration for publication elsewhere.
Correspondence to: Ana María García Vicente, PhD, Nuclear Medicine Department, University General Hospital, C/Obispo Rafael Torija s/n. 13005, Ciudad Real, Spain. E-mail: [email protected].
